Dyne Therapeutics Inc.

Dyne Therapeutics Inc.

World Rank (Aug-2026)
3727
Market Cap (Aug-2026)
4.799 Billion USD
Market Cap (Mar-08-2026)
2.452 Billion USD
World Rank (Jan-05-2024)
7,752
Market Cap (Jan-05-2024)
1.190 Billion USD
World Rank (Jul-30-2023)
10,793
Market Cap (Jul-30-2023)
0.686 Billion USD
World Rank (Jan-07-2022)
12,704
Market Cap (Jan-07-2022)
0.561 Billion USD
World Rank (Jan-01-2021)
8,142
Market Cap (Jan-01-2021)
0.954 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
DYN
Employee Count
2,117
Employee Count as of Date
As on 2020
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Operating Income in USD
-468 Million USD
Annual Net Income in USD
-446 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
1,187 Million USD
Total Liabilities in USD
215 Million USD
Total Equity in USD
972 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Company Website
DYNE THERAPEUTICS, INC.
Company Profile
Dyne Therapeutics is a Biotechnology company building a Muscle Disease company focused on advancing innovative life transforming therapeutics for people living with genetically driven diseases. The headquarters is in USA.
Facts About Company
Dyne Therapeutics company annual revenue was 0 million USD and annual net loss was  -168 million USD as on Dec-2022.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Medicinal Chemicals and Botanical Products

Share